Several RNAi studies targeting Survivin gene in vitro and in vivo were performed by using different carriers to deliver specifically and explore the roles of Survivin in cancer development and metastasis as well as the antitumor activity of anti-Survivin-siRNA in various cancer cell lines (Table 2). Here, BIRC5 is linked to cancer.